IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 148 filers reported holding IMMUNITYBIO INC in Q4 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $136,676 | +43.0% | 21,626 | +21.5% | 0.00% | 0.0% |
Q1 2024 | $95,586 | +102.7% | 17,800 | +89.5% | 0.00% | +100.0% |
Q4 2023 | $47,153 | +326.0% | 9,393 | +43.4% | 0.00% | – |
Q3 2023 | $11,068 | -71.3% | 6,549 | -52.8% | 0.00% | -100.0% |
Q2 2023 | $38,556 | +78585.7% | 13,869 | -48.7% | 0.00% | -50.0% |
Q1 2023 | $49 | +48.5% | 27,042 | +326.8% | 0.00% | +100.0% |
Q4 2022 | $33 | -99.9% | 6,336 | -1.7% | 0.00% | 0.0% |
Q3 2022 | $32,000 | +45.5% | 6,448 | +11.6% | 0.00% | – |
Q2 2022 | $22,000 | -89.9% | 5,778 | -85.1% | 0.00% | -100.0% |
Q1 2022 | $218,000 | +37.1% | 38,855 | +48.4% | 0.00% | -33.3% |
Q4 2021 | $159,000 | +37.1% | 26,182 | +119.6% | 0.00% | 0.0% |
Q3 2021 | $116,000 | +11.5% | 11,920 | +64.0% | 0.00% | 0.0% |
Q2 2021 | $104,000 | +166.7% | 7,269 | +343.5% | 0.00% | +200.0% |
Q1 2021 | $39,000 | – | 1,639 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |